Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prilosec OTC Continues To Gain Share Amid Advertising, Supply Pressures

This article was originally published in The Tan Sheet

Executive Summary

Procter & Gamble says sales of Prilosec OTC will face difficult year-over-year comparisons in the current quarter, indicating that growth for the heartburn drug may be slowing

You may also be interested in...



GSK Hopes To Energize Tagamet HB By Targeting New Male Audience

GlaxoSmithKline Consumer Healthcare is attempting to reinvigorate its OTC Tagamet heartburn remedy brand with a new marketing and advertising campaign targeting young males

P&G Healthcare Business Has $10 Bil. Potential – CEO Lafley

Procter & Gamble's healthcare unit could generate in excess of $10 bil. annually within a few years, according to CEO A.G. Lafley

P&G Leverages Prilosec OTC, Oral Care Products To Increase Market Leads

Procter & Gamble's Prilosec OTC has garnered nearly a quarter share of the over-the-counter stomach remedy category

Related Content

Topics

UsernamePublicRestriction

Register

PS097153

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel